CLINICAL PHARMACOKINETICS OF LABETALOL

被引:52
作者
MCNEIL, JJ
LOUIS, WJ
机构
关键词
D O I
10.2165/00003088-198409020-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:157 / 167
页数:11
相关论文
共 58 条
[2]   LABETALOL COMPARED WITH PRINDOLOL PLUS HYDRALLAZINE IN TREATMENT OF HYPERTENSION - DOUBLE-BLIND CROSSOVER STUDY [J].
BARNETT, AJ ;
KALOWSKI, S ;
GUEST, C .
MEDICAL JOURNAL OF AUSTRALIA, 1978, 1 (02) :105-109
[3]   EFFECTS OF LABETALOL (AH5158) ON ADRENERGIC TRANSMISSION IN CAT SPLEEN [J].
BLAKELEY, AGH ;
SUMMERS, RJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 59 (04) :643-650
[4]   THE ALPHA-ADRENOCEPTOR AND BETA-ADRENOCEPTOR BLOCKING POTENCIES OF LABETALOL AND ITS INDIVIDUAL STEREOISOMERS IN ANESTHETIZED DOGS AND IN ISOLATED-TISSUES [J].
BRITTAIN, RT ;
DREW, GM ;
LEVY, GP .
BRITISH JOURNAL OF PHARMACOLOGY, 1982, 77 (01) :105-114
[5]  
BROWN JJ, 1977, LANCET, V1, P1147
[6]  
COEVOET B, 1980, 2ND C INT SOC STUD H
[7]   THE SHORT-TERM EFFECTS OF PROPRANOLOL, ATENOLOL AND LABETALOL ON ANTIPYRINE KINETICS IN NORMAL SUBJECTS [J].
DANESHMEND, TK ;
ROBERTS, CJC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (06) :817-820
[8]  
DANESHMEND TK, 1982, BRIT J CLIN PHARMACO, V14, pP152
[9]  
DARGIE HJ, 1976, BRIT J CLIN PHARMACO, V3, P751
[10]   INHIBITION OF OXIDATIVE DRUG-METABOLISM BY BETA-ADRENOCEPTOR ANTAGONISTS IS RELATED TO THEIR LIPID SOLUBILITY [J].
DEACON, CS ;
LENNARD, MS ;
BAX, NDS ;
WOODS, HF ;
TUCKER, GT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (03) :429-431